HCA Healthcare (NYSE:HCA) Given Buy (B-) Rating at Weiss Ratings

HCA Healthcare (NYSE:HCA - Get Free Report)'s stock had its "buy (b-)" rating reiterated by stock analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

HCA has been the subject of a number of other research reports. Morgan Stanley decreased their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research note on Monday, July 28th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $444.00 target price on shares of HCA Healthcare in a research note on Tuesday. Robert W. Baird raised their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research note on Thursday, August 14th. Wells Fargo & Company raised their target price on shares of HCA Healthcare from $375.00 to $412.00 and gave the company an "equal weight" rating in a research note on Tuesday. Finally, Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average price target of $422.31.

HCA Healthcare Price Performance

NYSE HCA opened at $426.09 on Wednesday. The stock has a market capitalization of $99.70 billion, a PE ratio of 17.91, a PEG ratio of 1.38 and a beta of 1.40. HCA Healthcare has a 1 year low of $289.98 and a 1 year high of $439.01. The business's 50-day moving average is $402.68 and its 200 day moving average is $374.46.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same period last year, the firm earned $5.50 earnings per share. HCA Healthcare's quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts anticipate that HCA Healthcare will post 24.98 earnings per share for the current year.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.30% of the company's stock.

Institutional Trading of HCA Healthcare

A number of large investors have recently made changes to their positions in HCA. Wedmont Private Capital grew its holdings in HCA Healthcare by 2.4% during the 3rd quarter. Wedmont Private Capital now owns 3,560 shares of the company's stock valued at $1,558,000 after purchasing an additional 84 shares during the last quarter. Orser Capital Management LLC bought a new position in HCA Healthcare during the 3rd quarter valued at about $831,000. Norway Savings Bank grew its holdings in HCA Healthcare by 9.6% during the 3rd quarter. Norway Savings Bank now owns 4,255 shares of the company's stock valued at $1,813,000 after purchasing an additional 374 shares during the last quarter. Canandaigua National Bank & Trust Co. grew its holdings in HCA Healthcare by 2.3% during the 3rd quarter. Canandaigua National Bank & Trust Co. now owns 4,458 shares of the company's stock valued at $1,900,000 after purchasing an additional 102 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in HCA Healthcare by 1,877.1% during the 3rd quarter. Assenagon Asset Management S.A. now owns 117,361 shares of the company's stock valued at $50,019,000 after purchasing an additional 111,425 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.